Want to join the conversation?
$TRIP 2Q15 PR: Diluted earnings per share were $0.40 vs. $0.47 in 2Q14. Free cash flow was $177MM, or 44% of revenue, up 160% QoverQ and up 30% YoverY. TRIP enhanced its financial position by entering into a $1Bil five-year credit facility, which will be used for corporate purposes. Average monthly unique visitors grew 30% vs. 2Q14 to 375MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?